// App-Quantinova.ai

BSH2020‐EP‐094 : Real world outcomes for treatment of diffuse large B cell Lymphoma in patients aged 80 and over

Researchers

Presenter

  • R. Cooke

Principal Investigators

  • C. Williams

  • G. Holmes

Medical Centers

  • Northumbria Healthcare NHS Foundation Trust, Newcastle Upon Tyne

  • Northumbria Healthcare NHS Foundation Trust, Newcastle Upon Tyne

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

  • Oncology (ONC)

Disease

  • Diffuse large B-cell lymphoma

  • Congestive heart failure

  • Lung Cancer

  • Lymphomas

  • Dementia

  • Solid malignancies

Biomarkers

  • DNA Damage Inducible Transcript 3

  • Hematocrit

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • chlorambucil

  • Etoposide

  • Etoposide phosphate

  • Lomustine

  • Rituximab

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved